As of Nov 19, 2026, 2 of 2 active firms rate MESO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
MESO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.07 – $-0.07 · 1 analysts
Next period, 1 analysts expect Mesoblast Ltd to earn $-0.07 a share (range $-0.07 – $-0.07), versus — a year earlier. Full-year consensus is $-0.12, growing to $0.35 the year after.
REVENUE · NEXT QUARTER
$57.2M
Range $57.2M – $57.2M · 1 analysts · +33% YoY
Revenue is expected to reach $57.2M (range $57.2M – $57.2M), +33.4% year-over-year. Full-year consensus is $236.1M, rising to $361.3M next year.
Top analysts covering Mesoblast Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MESO.
#1
Edward Tenthoff
Piper Sandler · Rank #460
Buy
$39.00+234.8% to target
Overall win rate
29%
+ Follow
#2
Jason McCarthy
Maxim Group · Rank #567
Buy
$35.00+200.4% to target
Overall win rate
30%
+ Follow
#3
DS
David Stanton
Jefferies
Buy
No targeton MESO
Coverage
—
+ Follow
#4
Joshua Schimmer
Cantor Fitzgerald
Buy
No targeton MESO
Coverage
—
+ Follow
MESO stock forecast FAQ
What is MESO's average 12-month price target?+
The 1 active firms with a live target average $39.00 for Mesoblast Ltd over the next 12 months, ranging from a $39.00 high to a $39.00 low, as of Nov 19, 2026.
Is MESO stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover MESO?+
2 active firms have a recognized rating on Mesoblast Ltd as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering MESO?+
Among analysts who currently cover MESO, Edward Tenthoff of Piper Sandler has the strongest overall Quantellect track record (Rank #460). Their current call is Buy with a $39.00 target.
What is Mesoblast Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.07 – $-0.07) across 1 analysts. Full-year EPS is projected at $-0.12, rising to $0.35 the following year.
How much revenue is Mesoblast Ltd expected to report next quarter?+
Consensus revenue is $57.2M (range $57.2M – $57.2M). Full-year revenue is projected at $236.1M, growing to $361.3M next year.
Have analysts been upgrading or downgrading MESO lately?+
As of Nov 19, 2026, 2 of 2 active firms rate MESO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MESO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.